Dianthus Therapeutics Stock Forecast

Stock Price Forecast

According to 15 analysts polled by S&P Global, Dianthus Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $125.83. The average 1-year stock price forecast is 45.18% higher than the current stock price, while the lowest is $98 (+13.07%) and the highest is $200 (+130.76%).

Price Target: $125.83 (+45.18%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$98	$125.83	$122.5	$200
Change	+13.07%	+45.18%	+41.34%	+130.76%

Analyst Ratings

The average analyst rating for Dianthus Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	13	13	13	15	16	15
Buy	1	1	1	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	14	14	14	15	16	15

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Gavin Clark-Gartner Evercore ISI	Evercore ISI	Buy Maintains $122 → $120	Buy	Maintains	$122 → $120	+38.46%	May 11, 2026
Rami Katkhuda LifeSci Capital	LifeSci Capital	Buy Maintains $125	Buy	Maintains	$125	+44.23%	May 10, 2026
Danielle Brill Truist Financial	Truist Financial	Buy Maintains $110	Buy	Maintains	$110	+26.92%	May 7, 2026
Ryan Deschner Raymond James	Raymond James	Buy Maintains $123 → $125	Buy	Maintains	$123 → $125	+44.23%	May 7, 2026
Swayampakula Ramakanth H.C. Wainwright	H.C. Wainwright	Buy Reiterates $130	Buy	Reiterates	$130	+49.99%	May 6, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

1.27M

from 2.04M

-37.67%

from 2.04M

Revenue Next Year

1.49M

from 1.27M

17.02%

from 1.27M

EPS This Year

-3.93

from -4.20

EPS Next Year

-4.51

from -3.93

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	1.48M	6.42M	2.83M	6.24M	2.04M	1.27M	1.49M
Revenue Growth	-	334.76%	-55.96%	120.63%	-67.35%	-37.67%	17.02%
EPS	-3.27	-32.57	-8.45	-2.55	-4.20	-3.93	-4.51
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	16	16

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	3.8M	6.3M
Avg	1.3M	1.5M
Low	n/a	n/a

Revenue Growth

Revenue Growth	2026	2027
High	85.7%	396.5%
Avg	-37.7%	17.0%
Low	-	-

EPS Forecast

EPS	2026	2027
High	-2.80	-2.92
Avg	-3.93	-4.51
Low	-6.02	-5.44

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.